Results of a single ascending dose study to assess the safety and tolerability of CNTO 1959 following intravenous or subcutaneous administration in healthy subjects and in subjects with moderate to severe psoriasis

Authors
Category Primary study
ConferenceBritish Journal of Dermatology
Year 2011
This article has no abstract
Epistemonikos ID: 48bd76451b3ec4abb59dca1c4edf97bad4f6371a
First added on: Apr 30, 2026